Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
81.0%
% of IHE's 42 holdings also in XPH
85.0%
% of XPH's 40 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ROYALTY PHARMA PLC CLASS A | 4.8% | 4.5% | 4.5% |
|
ELI LILLY & CO | 5.0% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 4.3% | 4.3% |
|
PFIZER INC | 4.6% | 4.3% | 4.3% |
|
ZOETIS INC | 4.5% | 4.3% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 18.8% |
|
MERCK & CO. INC. | 15.6% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.1% |
|
AMICUS THERAPEUTICS INC | 1.1% |
|
CATALYST PHARMACEUTICAL PART | 0.6% |
|
IRONWOOD PHARMACEUTICALS INC | 0.6% |
|
ELI LILLY & CO | 0.5% |
|
PFIZER INC | 0.3% |
|
BRISTOL-MYERS SQUIBB CO | 0.3% |
|
CATALENT INC | 0.3% |
IHE Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
PROVENTION BIO, INC. | -3.4% |
|
CASSAVA SCIENCES, INC. | -3.2% |
|
REVANCE THERAPEUTICS INC | -2.5% |
|
ELANCO ANIMAL HEALTH, INC. | -2.3% |
 |
PERRIGO CO | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.0% |
|
ORGANON & CO. | -1.8% |
|
VENTYX BIOSCIENCES, INC. | -1.7% |